Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$8K 1325
2022
Q3
$8K Hold
200
﹤0.01% 1065
2022
Q2
$7K Hold
200
﹤0.01% 1090
2022
Q1
$10K Hold
200
﹤0.01% 1081
2021
Q4
$10K Buy
+200
New +$9.47K ﹤0.01% 1061

Other funds holding SNV

Central Trust Company's SNV Position: Q4 2022 in Review

Central Trust Company sold out of Synovus (SNV) in Q4 2022, closing a stake of 200 shares — an estimated $8K sold.

Central Trust Company first reported a position in SNV in Q4 2021 and held it in 4 quarters. The position peaked at $10K in Q1 2022. 419 funds tracked by Wall St. Rank hold SNV as of Q4 2022.

  • Central Trust Company reported no remaining Synovus position as of Q4 2022 after selling out during the quarter.
  • Central Trust Company sold 200 Synovus shares in Q4 2022, an estimated $8K.
  • Central Trust Company first reported a position in Synovus in Q4 2021 and held it in 4 quarters.
  • Central Trust Company's Synovus position peaked at $10K in Q1 2022.
  • 419 funds tracked by Wall St. Rank held Synovus as of Q4 2022.

Based on Central Trust Company's 13F filing for Q4 2022, filed 26 Jan 2023.